Suppr超能文献

回到什么?研究伦理在大流行时期的作用。

Back to WHAT? The role of research ethics in pandemic times.

作者信息

Solbakk Jan Helge, Bentzen Heidi Beate, Holm Søren, Heggestad Anne Kari Tolo, Hofmann Bjørn, Robertsen Annette, Alnæs Anne Hambro, Cox Shereen, Pedersen Reidar, Bernabe Rose

机构信息

Faculty of Medicine, Center for Medical Ethics, Institute of Health and Society, University of Oslo, Blindern, Box 1130, 0318, Oslo, Norway.

Faculty of Law, Norwegian Research Center for Computers and Law, University of Oslo, Oslo, Norway.

出版信息

Med Health Care Philos. 2021 Mar;24(1):3-20. doi: 10.1007/s11019-020-09984-x. Epub 2020 Nov 3.

Abstract

The Covid-19 pandemic creates an unprecedented threatening situation worldwide with an urgent need for critical reflection and new knowledge production, but also a need for imminent action despite prevailing knowledge gaps and multilevel uncertainty. With regard to the role of research ethics in these pandemic times some argue in favor of exceptionalism, others, including the authors of this paper, emphasize the urgent need to remain committed to core ethical principles and fundamental human rights obligations all reflected in research regulations and guidelines carefully crafted over time. In this paper we disentangle some of the arguments put forward in the ongoing debate about Covid-19 human challenge studies (CHIs) and the concomitant role of health-related research ethics in pandemic times. We suggest it might be helpful to think through a lens differentiating between risk, strict uncertainty and ignorance. We provide some examples of lessons learned by harm done in the name of research in the past and discuss the relevance of this legacy in the current situation.

摘要

新冠疫情在全球造成了前所未有的威胁局面,迫切需要进行批判性反思和新知识生产,同时尽管存在普遍的知识空白和多层次的不确定性,也需要立即采取行动。关于研究伦理在这些疫情时期的作用,一些人主张采取特殊主义,而包括本文作者在内的其他人则强调迫切需要继续致力于核心伦理原则和基本人权义务,这些都体现在经过长期精心制定的研究法规和指南中。在本文中,我们梳理了关于新冠病毒人体挑战研究(CHIs)的 ongoing 辩论中提出的一些论点,以及健康相关研究伦理在疫情时期的伴随作用。我们建议,通过区分风险、严格不确定性和无知的视角来思考可能会有所帮助。我们提供了一些过去以研究之名造成伤害的经验教训的例子,并讨论了这一 legacy 在当前形势下的相关性。

相似文献

1
Back to WHAT? The role of research ethics in pandemic times.
Med Health Care Philos. 2021 Mar;24(1):3-20. doi: 10.1007/s11019-020-09984-x. Epub 2020 Nov 3.
2
HIV prevention research and COVID-19: putting ethics guidance to the test.
BMC Med Ethics. 2021 Jan 25;22(1):6. doi: 10.1186/s12910-021-00575-w.
4
Virtue ethics and the unsettled ethical questions in controlled human infection studies.
Bioethics. 2024 Oct;38(8):692-701. doi: 10.1111/bioe.13326. Epub 2024 Jun 17.
5
Ethics review in compassionate use.
BMC Med. 2017 Jul 24;15(1):136. doi: 10.1186/s12916-017-0910-9.
6
COVID-19 and its intersect with ethics and human rights in Sub-Saharan Africa.
J Infect Dev Ctries. 2021 Jul 31;15(7):910-12. doi: 10.3855/jidc.14795.
8
Responses to open peer commentaries on "research exceptionalism".
Am J Bioeth. 2010 Aug;10(8):W4-6. doi: 10.1080/15265161.2010.489415.
9
The Ethics of Expanded Access Research.
JAMA. 2023 Apr 4;329(13):1057-1058. doi: 10.1001/jama.2023.2204.
10
Ethical guidelines for deliberately infecting volunteers with COVID-19.
J Med Ethics. 2020 Aug;46(8):502-504. doi: 10.1136/medethics-2020-106322. Epub 2020 May 27.

引用本文的文献

1
The Politicization of Research Ethics and Integrity and its Implications for Research Governance.
J Acad Ethics. 2025;23(3):759-765. doi: 10.1007/s10805-024-09563-2. Epub 2024 Oct 28.
2
Government Initiatives for Research Ethics During COVID-19 Pandemic in Korea.
J Korean Med Sci. 2024 Apr 1;39(12):e116. doi: 10.3346/jkms.2024.39.e116.
4
A new day for human challenge trials?
Trends Mol Med. 2022 Jul;28(7):531-532. doi: 10.1016/j.molmed.2022.05.002. Epub 2022 May 22.
5
Accessibility to Non-COVID Health Services in the World During the COVID-19 Pandemic: Review.
Front Public Health. 2021 Dec 16;9:760795. doi: 10.3389/fpubh.2021.760795. eCollection 2021.

本文引用的文献

1
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
2
On the importance of early testing even when imperfect in a pandemic such as COVID-19.
Glob Epidemiol. 2020 Nov;2:100031. doi: 10.1016/j.gloepi.2020.100031. Epub 2020 Aug 3.
3
Long-term consequences of COVID-19: research needs.
Lancet Infect Dis. 2020 Oct;20(10):1115-1117. doi: 10.1016/S1473-3099(20)30701-5. Epub 2020 Sep 1.
4
An ethical framework for global vaccine allocation.
Science. 2020 Sep 11;369(6509):1309-1312. doi: 10.1126/science.abe2803. Epub 2020 Sep 3.
5
The Regulation of COVID-19 "Challenge" Studies.
Am J Bioeth. 2020 Jul;20(7):80-82. doi: 10.1080/15265161.2020.1779393.
6
The first casualty of an epidemic is evidence.
J Eval Clin Pract. 2020 Oct;26(5):1344-1346. doi: 10.1111/jep.13443. Epub 2020 Jul 22.
7
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.
N Engl J Med. 2020 Sep 3;383(10):e63. doi: 10.1056/NEJMp2020076. Epub 2020 Jul 1.
8
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
Vaccine. 2020 Jul 14;38(33):5085-5088. doi: 10.1016/j.vaccine.2020.06.007. Epub 2020 Jun 4.
9
10
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.
Ann Intern Med. 2020 Sep 1;173(5):362-367. doi: 10.7326/M20-3012. Epub 2020 Jun 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验